Cajal Neuroscience
cajalneuro.comLocations
Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
51-200 employees
Stage
Series A
founded in
2020
Cajal Neuroscience is a biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. The company combines a suite of state-of-the-art approaches and technologies, including integrative human genetics and multi-omics, high-throughput functional genomics, and advanced microscopy, to accelerate neurodegeneration target and drug discovery.
Something looks off?Open jobs at Cajal Neuroscience
On-site & Remote